Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Hikma Pharmaceuticals Fundamentals

Company Name Hikma Pharmaceuticals Last Updated 14 Oct 2019
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 242.30 Market Cap (£m) 4,901.67
PE Ratio 17.29 Div per Share ($) 38.00
Div Yield 1.57 Div Cover 2.93
EPS 117.00 EPS Growth (%) 133.26
PEG 0.13 DPS Growth (%) 11.76
Debt Ratio 34.83 Debt Equity Ratio 0.50
Net Gearing 43.58 Gross Gearing 51.47
Asset Equity Ratio 2.06 Cash Equity Ratio 16.26
Quick Ratio 1.28 Current Ratio 1.87
Price To Book Value 2.89 ROCE 11.25

Hikma Pharmaceuticals Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
H1 Dividend 22 Aug 2019 23 Sep 2019 USX 14.00
H2 Dividend 04 Apr 2019 22 May 2019 USX 26.00 38.00
H1 Dividend 23 Aug 2018 21 Sep 2018 USX 12.00
H2 Dividend 05 Apr 2018 24 May 2018 USX 23.00 34.00
H1 Dividend 24 Aug 2017 22 Sep 2017 USX 11.00
H2 Dividend 06 Apr 2017 25 May 2017 USX 22.00 33.00
H1 Dividend 01 Sep 2016 30 Sep 2016 USX 11.00
H2 Dividend 07 Apr 2016 19 May 2016 USX 21.00 32.00
H1 Dividend 27 Aug 2015 25 Sep 2015 USX 11.00
H2 Dividend 16 Apr 2015 21 May 2015 USX 15.00 22.00
H1 Dividend 27 Aug 2014 26 Oct 2014 USX 7.00

Hikma Pharmaceuticals Company Financials

Assets (£m) 2018 2017 2016
Tangible Assets 870 828 969
Intangible Assets 766 785 1,719
Investments 193 201 227
Total Fixed Assets 1,829 1,814 2,915
Stocks 528 488 459
Debtors 731 707 759
Cash & Equivalents 276 227 155
Other Assets 133 152 75
Total Assets 3,497 3,388 4,363
Liabilities (£m) 2018 2017 2016
Creditors within 1 year 893 797 918
Creditors after 1 year 907 1,063 1,034
Other Liabilities 0 0 0
Total Liabilities 1,800 1,860 1,952
Net assets 1,697 1,528 2,411
Equity (£m) 2018 2017 2016
Called up share capital 40 40 40
Share Premium 282 282 282
Profit / Loss 293 -738 210
Other Equity -217 1,192 2,074
Preference & Minorities 12 14 15
Total Capital Employed 1,697 1,528 2,411
Ratios 2018 2017 2016
Debt Ratio 34.83 41.03 30.02
Debt-to-Equity 0.50 0.57 0.53
Net Gearing 43.58 48.20 41.19
Gross Gearing 51.47 54.90 44.74
Assets / Equity 2.06 2.22 1.81
Cash / Equity 16.26 14.86 6.43
EPS 117.00 -351.80 66.50
Cash Flow (£m) 2018 2017 2016
Cash from operating activities 430 443 293
Cashflow before financing 334 292 -402
Increase in Cash 56 72 -383
Income (£m) 2018 2017 2016
Turnover 2,070 1,936 1,950
Cost of sales 1,020 969 964
Gross Profit 1,050 967 986
Operating Profit 371 -747 302
Pre-Tax profit 293 -738 210
Profit / Loss for the year 40 40 40

Hikma Pharmaceuticals Company Background

Sector Pharmaceuticals
Activities Hikma Pharmaceuticals plc principal activities are the development, manufacture, and marketing of a broad range of branded and non-branded generic pharmaceuticals products across the US, the Middle East and North Africa (MENA) and Europe. Hikma is also a leading licensing partner in MENA.
Latest Interim Date 09 Aug 2019
Latest Fiscal Year End Date 13 Mar 2019

Hikma Pharmaceuticals Directors

Appointed Director Position
20 Feb 2018 Sigurdur Oli Olafsson Chief Executive Officer
01 Jul 2007 Said Samih Darwazah Executive Chairman
01 Nov 2005 Mazen Samih Darwazah Executive Vice Chairman
01 Oct 2016 Mary Regina Henderson Non-Executive Director
01 Dec 2014 Dr Pamela Josephine Kirby Non-Executive Director
01 Sep 2011 Robert Mark Pickering Non-Executive Director
01 Jun 2019 Cynthia Louise Schwalm Non-Executive Director
24 Dec 2015 Dr Jochen Gann Non-Executive Director
01 Mar 2016 John Julius Castellani Non-Executive Director
01 Apr 2014 Patrick Noel Butler Non-Executive Director
01 Nov 2005 Ali Mohammed Al-Husry Non-Executive Director

Hikma Pharmaceuticals Contact Details

Company Name Hikma Pharmaceuticals
Company Address 13 Hanover Square, London W1S 1HL.
Company Telephone +44 (0)20 7399 2760
Company Website http://www.hikma.com/

Hikma Pharmaceuticals Advisors

Auditor Name Deloitte & Touche LLP
Auditor Address 2 New Street Square, London EC4A 3BZ.
Auditor Website http://www.deloitte.com/
Auditor Telephone +44 (0)20 7936 3000
Registrar Name Link Asset Services
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.linkassetservices.com/
Registrar Telephone 0870 162 3100
Broker Name Citigroup Global Markets
Broker Address Citigroup Centre, 33 Canada Square, Canary Wharf, London E14 5LB.
Broker Website http://www.citi.com/
Broker Telephone +44 (0)20 7986 4000
Adviser Name n/a
Adviser Address n/a
Adviser Website n/a
Adviser Telephone n/a
Solicitor Name Ashurst LLP
Solicitor Address Broadwalk House, 5 Appold Street, London EC2A 2HA.
Solicitor Website http://www.ashurst.com/
Solicitor Telephone +44 (0)20 7638 1111
Stockbroker Name Merrill Lynch International
Stockbroker Address Merrill Lynch Financial Centre, 2 King Edward Street, London, EC1A 1HQ.
Stockbroker Website http://www.ml.com/
Stockbroker Telephone +44 (0)20 7628 1000